Napredna pretraga

Pregled bibliografske jedinice broj: 933655

Efficacy and safety of biosimilar infliximab (Inflectra) in patients with ankylosing spondylitis: multicentre and observational one year follow-up study


F. Grubisic, S. Grazio, B. Anic, M. Baresic, S. Novak, F. Anic, V. Prus, A. G. Gracanin, J. Morovic Vergles, D.M. Kaliterna, K. Boric, T. Kehler
Efficacy and safety of biosimilar infliximab (Inflectra) in patients with ankylosing spondylitis: multicentre and observational one year follow-up study // International Journal of Rheumatic Diseases, 20 (2017), 1; 51-51 (međunarodna recenzija, članak, ostalo)


Naslov
Efficacy and safety of biosimilar infliximab (Inflectra) in patients with ankylosing spondylitis: multicentre and observational one year follow-up study

Autori
F. Grubisic, S. Grazio, B. Anic, M. Baresic, S. Novak, F. Anic, V. Prus, A. G. Gracanin, J. Morovic Vergles, D.M. Kaliterna, K. Boric, T. Kehler

Izvornik
International Journal of Rheumatic Diseases (1756-1841) 20 (2017), 1; 51-51

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo

Ključne riječi
(biosimilar, infliximab, ankylosing spondylitis)

Sažetak
The aim of the study was to evaluate the efficacy and safety of biosimilar Inflectra in patients with AS.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE